Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short S&P500 ETF
SPXU
5
Short Russell 2000 Proshares
RWM
US Stock MarketDetailed Quotes
SOPH Sophia Genetics
- 3.110
- +0.040+1.30%
Close May 15 16:00 ET
- 3.080
- -0.030-0.96%
Post 16:05 ET
207.81MMarket Cap-3.11P/E (TTM)
3.220High3.030Low7.29KVolume3.030Open3.070Pre Close22.82KTurnover0.01%Turnover RatioLossP/E (Static)66.82MShares6.28052wk High2.43P/B162.03MFloat Cap2.58052wk Low--Dividend TTM52.10MShs Float19.800Historical High--Div YieldTTM6.19%Amplitude1.685Historical Low3.132Avg Price1Lot Size
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Sophia Genetics Stock Forum
-- Revenue was $17.8 million, up 13% year-over-year or 15% on a constant
currency basis
-- Gross margin was 68.7% on a reported basis and 75.7% on an adjusted basis,
up from 65.9% and 70.5% in the prior year period, respectively
-- IFRS net loss increased 27% year-over-year to $17.4 million (including a net foreign exchange P&L impact of $5.2 million), and adjusted EBITDA
loss improved 24% year-over-year to $9.8 million ...
Major AI Breakthrough: SOPHiA GENETICS Partners to Transform Clinical Trial Analysis
SOPHiA GENETICS Hits Major AI Breakthrough: 2M Patient Genomic Profiles Analyzed Worldwide
SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC
Tuesday, 18th March at 9:00 am
BOSTON, MA and ROLLE, Switzerland, March 18, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI-powered analytics Platform SOPHiA DDM™. This ...
Global Healthcare Revolution: Elite Hospitals Rush to Implement This Game-Changing Cancer Test
PR Newswire· 3 mins ago
The cutting-edge OncoPortal Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers
SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities
Tuesday, 28th January at 8:46 am
The cutting-edge OncoPortal™ Mutation Tracker add-on module enables precision monitoring of evolving genomic cancer drivers
BOSTON, MA and ROLLE, Switzerland, Jan. 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, has unveiled the OncoPortal™ Mutation Tracker — a longitud...
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024
SOPHiA GENETICS (Nasdaq: SOPH) will present groundbreaking research at ESMO 2024, showcasing AI-driven patient stratification for non-small cell lung cancer (NSCLC) treatment.
The study, conducted with AstraZeneca, analyzed the POSEIDON Phase 3 clinical trial using multimodal machine learningto identify NSCLC patient subgroups most likely to benefit...
No comment yet